Skip to main content
Home
Main navigation
  • Contents
    • Reactions
    • Expert voices
    • What we know
    • Resource library
    • Briefings
    • Training
    • SMC Studies
  • Journalists
  • Scientists
  • Press offices
  • About SMC ES
    • About SMC ES
    • The 5Ws +1
    • Statute
    • Advisory Committee
    • Working Method
    • Governance
    • Team
    • FAQ
  • Global network
User account menu - Secondary
  • ES
  • EN

Breadcrumb

  1. Home
Autor/es reacciones

John Hardy

Professor of Neuroscience and Group Leader at the UK Dementia Research Institute, UCL.

EMA revises earlier decision and decides to approve lecanemab for Alzheimer's disease
EN
Home
Science Media Centre Spain
 
 
Sobre SMC
  • What is the SMC Spain
  • Statute
  • Advisory Committee
  • CC Licence
  • FAQ
Contact the SMC

Do you have any questions or suggestions?

Write to us
Información
  • Legal Notice and Privacy Policy
  • Cookies Policy
  • Accesibilidad
© Science Media Centre 2021